LYRA - Lyra Therapeutics, Inc.
IEX Last Trade
0.1924
0.003 1.559%
Share volume: 21,674
Last Updated: Fri 27 Dec 2024 08:22:21 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$0.19
0.00
1.58%
Summary score
19%
Profitability
18%
Dept financing
10%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.97%
Return on assets
-13.82%
Return on sales
-22335.57%
Return on invested capital
-1513.16%
Total debt ratio
25.18%
Debt ratio change over timeo
-0.97%
Current Ratio
9.29%
Quick Ratio
8.39%
Cash Position Ratio
9.06%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.09%
Return on assets
-13.5%
Return on sales
-5514.07%
Return on invested capital
130%
Total debt ratio
33.56%
Debt ratio change over timeo
-1.25%
Current Ratio
5.99%
Quick Ratio
5.99%
Cash Position Ratio
5.86%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-28.97%
Return on assets
-16.62%
Return on sales
-4421.8%
Return on invested capital
-67.3%
Total debt ratio
45.24%
Debt ratio change over time
-1.54%
Current Ratio
4.78%
Quick Ratio
4.78%
Cash Position Ratio
4.65%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.48%
Return on assets
-103.24%
Return on sales
-8791.74%
Return on invested capital
48.65%
Total debt ratio
-97.29%
Debt ratio change over time
-0.97%
Current Ratio
0.01%
Quick Ratio
0.1%
Cash Position Ratio
-0.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LYRA | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -19.97% | 18.83% | 17.34% | 7.6% |
| Return on assets | -13.82% | 4.16% | 8.21% | 3.22% |
| Return on sales | -22335.57% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | -1513.16% | 9.79% | -219.55% | 7.46% |
| Profitability | 0% | 80% | 73% | 54% |
| Total debt ratio | 25.18% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -0.97% | -4.38% | -0.73% | -33.74% |
| Dept financing | 8% | 25% | 42% | 18% |
| Current Ratio | 5.99% | 1.12% | 0% | 1.16% |
| Quick Ratio | 5.99% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 5.86% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 7% | 6% | 8% |
| Short-term ratios | LYRA | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -20.09% | 13.31% | 0% | 13.48% |
| Return on assets | -13.5% | 4.72% | 0% | 3.05% |
| Return on sales | -5514.07% | 31.4% | 0% | 25.56% |
| Return on invested capital | 130% | 10.68% | 0% | 13.96% |
| Profitability | 25% | 77% | 0% | 64% |
| Total debt ratio | 33.56% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -1.25% | -41.82% | 0% | 7.13% |
| Dept financing | 10% | 25% | 0% | 43% |
| Current Ratio | 5.99% | 1.12% | 0% | 1.16% |
| Quick Ratio | 5.99% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 5.86% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 9% | 0% | 11% |